Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs)

被引：23

作者：

Handlon, Anthony L. ^{[1
]}

Schaller, Lee T.

Leesnitzer, Lisa M. ^{[2
]}

Merrihew, Raymond V.

Poole, Chuck

Ulrich, John C.

Wilson, Joseph W.

Cadilla, Rodolfo

Turnbull, Philip ^{[3
]}

机构：

[1] GlaxoSmithKline, Metab Pathways Cardiovasc Unit, 709 Swedeland Rd, King Of Prussia, PA 19406 USA

[2] Quintiles, Plaza Bldg,4820 Emperor Blvd, Durham, NC 27703 USA

[3] Receptos Inc, 3033 Sci Pk Rd,Suite 300, San Diego, CA 92121 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 01期

关键词：

ligand efficiency; LLE; androgen receptor; selective androgen receptor modulator; SARM; DRUG DISCOVERY; MEN; METRICS; IMPACT; WOMEN; ACID;

D O I：

10.1021/acsmedchemlett.5b00377

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of selective androgen receptor modulators (SARMs) containing the 1-(trifluoromethyl)benzyl alcohol core have been optimized for androgen receptor (AR) potency and drug-like properties. We have taken advantage of the lipophilic ligand efficiency (LLE) parameter as a guide to interpret the effect of structural changes on AR activity. Over the course of optimization efforts the LLE increased over 3 log units leading to a SARM 43 with nanomolar potency, good aqueous kinetic solubility (>700 mu M), and high oral bioavailability in rats (83%).

引用

页码：83 / 88

页数：6

共 50 条

[1] Optimizing ligand efficiency of selective androgen receptor modulators (SARMs)
Handlon, Anthony
Cadilla, Rodolfo
Leesnitzer, Lisa
Merrihew, Raymond
Poole, Chuck
Ulrich, John
Wilson, Joseph
Turnbull, Philip
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[2] Development of selective androgen receptor modulators (SARMs)
Narayanan, Ramesh
Coss, Christopher C.
Dalton, James T.
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2018, 465 (0C) : 134 - 142
[3] Novel selective androgen receptor modulators (SARMs).
Miller, DD
He, YL
Marhefka, CA
Rakov, IM
Hong, SS
Hwang, DJ
Mohler, ML
Kirichenko, SN
Mustafa, SM
Nair, VA
Patil, R
Chung, KW
Veverka, KA
Steiner, MS
Barnette, KG
Yin, DH
Gao, WQ
Kearbey, JD
Xu, HP
Kim, J
Chen, JY
Bohl, C
Dalton, JT
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U1 - U1
[4] SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMs) IN THE CONTEXT OF DOPING
Miklos, Amalia
Tero-Vescan, Amelia
Vari, Camil-Eugen
Osz, Bianca-Eugenia
Filip, Cristina
Rusz, Carmen-Maria
Muntean, Daniela-Lucia
FARMACIA, 2018, 66 (05) : 758 - 762
[5] RECENT PROGRESS WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMs)
Dalton, James T.
Narayanan, Ramesh
Kearbey, Jeffrey D.
Coss, Christopher C.
Bob, Casey E.
Jones, Amanda
Barnette, K. Gary
Rodriguez, Domingo
Hancock, Michael
Morton, Ronald A.
Steiner, Mitchell S.
JOURNAL OF ANDROLOGY, 2009, 30 : 21 - 22
[6] Chapter 17. Selective androgen receptor modulators (SARMs)
Zhi, L
Martinborough, E
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36, 2001, 36 : 169 - 180
[7] Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer
Hwang, Dong Jin
Yang, Jun
Xu, Huiping
Rakov, Igor M.
Mohler, Michael L.
Dalton, James T.
Miller, Duane D.
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (19) : 6525 - 6538
[8] Tissue selective androgen receptor modulators (SARMs): A path to a clinical candidate
Chekler, Eugene
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[9] Selective androgen receptor modulators (SARMs): A novel approach to androgen therapy for the new millennium
Negro-Vilar, A
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10): : 3459 - 3462
[10] Synthesis of potent, substituted carbazoles as selective androgen receptor modulators (SARMs)
Miller, Chris P.
Bhaket, Pushpal
Muthukaman, Nagarajan
Lyttle, C. Richard
Shomali, Maysoun
Gallacher, Kyla
Slocum, Connie
Hattersley, Gary
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7516 - 7520

← 1 2 3 4 5 →